Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

SWOG 1312 Final Results: A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemia

Anjali S. Advani, MD, Anna Moseley, M.S., Michaela Liedtke, MD, Margaret R O'Donnell, MD, Ibrahim Aldoss, MD, Martha P. Mims, MD PhD, Kristen Marie O'Dwyer, MD, Megan Othus, PhD, Harry P. Erba, MD PhD

Blood (2019) 134 (Supplement_1): 227.

https://doi.org/10.1182/blood-2019-125340

Published: 2019

Journal Articles

Safety Analysis of Two Randomized Controlled Studies of Venetoclax in Patients with Chronic Lymphocytic Leukemia

Samer Al Hadidi, MDMSc, Rammurti Kamble, MD, Courtney Nicole Miller-Chism, MD, Martha P. Mims, MD PhD

Blood (2019) 134 (Supplement_1): 5472.

https://doi.org/10.1182/blood-2019-126353

Published: 2019

Journal Articles

Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk Stratification

Aimaz Afrough, MD, Rafee Talukder, MD, Sarvari Venkata Yellapragada, MD, Purnima Sravanti Teegavarapu, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD

Blood (2019) 134 (Supplement_1): 2678.

https://doi.org/10.1182/blood-2019-129183

Published: 2019

Journal Articles

Safety Analysis of Five Randomized Controlled Studies of Daratumumab in Patients with Multiple Myeloma

Samer Al Hadidi, MDMSc, Rammurti Kamble, MD, Courtney Nicole Miller-Chism, MD, Martha P. Mims, MD PhD

Blood (2019) 134 (Supplement_1): 3175.

https://doi.org/10.1182/blood-2019-126341

Published: 2019

Journal Articles

Superior Outcome in Elderly AML Patients Receiving Adjuvant Serotonin-Reuptake-Inhibitors during Induction

Rafee Talukder, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD

Blood (2019) 134 (Supplement_1): 1438.

https://doi.org/10.1182/blood-2019-131581

Published: 2019

Journal Articles

A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemia (SWOG 1312)

Anjali S. Advani, MD, Anna Moseley, Michaela Liedtke, MD, Margaret O'Donnell, MD, Megan Othus, PhD, Martha P. Mims, MD PhD, Kristen O'Dwyer, MD, Harry P. Erba, MD PhD

Blood (2016) 128 (22): 1634.

https://doi.org/10.1182/blood.V128.22.1634.1634

Published: 2016

Journal Articles

Traceable Red Cell Distribution Width Modifications Are Observed Prior to MDS Diagnosis and Primarily Associated with Cardiovascular Organ Dysfunction

Claudia Rodriguez, MD,, Alcedo Pedro, Sarvari Venkata Yellapragada, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD

Blood (2016) 128 (22): 5537.

https://doi.org/10.1182/blood.V128.22.5537.5537

Published: 2016

Journal Articles

Southwest Oncology Group Study S0530: A Phase 2 Trial of Clofarabine/ Cytarabine for Relapsed/ Refractory Acute Lymphocytic Leukemia.

Anjali Advani, MD, Holly Gundacker, MS, Olga Sala-Torra, MD, Jerald Radich, MD, Raymond Lai, MD, PhD, Marilyn L. Slovak, PhD, Jeffrey E Lancet, MD, Steve Coutre, MD, Robert K Stuart, MD, Martha P. Mims, MD, PhD, Patrick Stiff, MD, Frederick R. Appelbaum, MD

Blood (2009) 114 (22): 3094.

https://doi.org/10.1182/blood.V114.22.3094.3094

Published: 2009

Journal Articles

8p11–12 Myeloprolferative Syndrome: A Case Report and Brief Review of the Literature

Sarvari Venkata Yellapragada, MD, Martha P. Mims, MD, PhD, Courtney Jackson, MD, Mark Lewis, MD, Mark M. Udden, MD

Blood (2008) 112 (11): 5260.

https://doi.org/10.1182/blood.V112.11.5260.5260

Published: 2008

Journal Articles

Polyclonal PRAME-Specific Cytotoxic T Lymphocytes Generated Using Protein-Spanning Pools of Overlapping Pentadecapeptides Target Chronic Myeloid Leukemia

Concetta Quintarelli, PhD, Gianpietro Dotti, MD, Biagio De Angelis, PhD, Valentina Hoyos, MD, Fabrizio Pane, MD, Martha P. Mims, MD, PhD, Helen E. Heslop, MD, Cliona M Rooney, PhD, Malcolm K Brenner, MD, PhD, Barbara Savoldo, MD

Blood (2008) 112 (11): 3899.

https://doi.org/10.1182/blood.V112.11.3899.3899

Published: 2008

Journal Articles

Risk and Therapeutic Outcomes in a Multiethnic Group of Acute Lymphoblastic Leukemia Patients Treated at a Large Public Hospital

Yuval Raizen, MD, Mark M. Udden, MD, Hao Liu, PhD, Meng-Fen Wu, Martha P. Mims, MD, PhD

Blood (2008) 112 (11): 3938.

https://doi.org/10.1182/blood.V112.11.3938.3938

Published: 2008

Journal Articles

Presence of Alpha Thalassemia Trait Complicating the Diagnosis of Polycythemia Vera in a Pediatric Patient.

Shannon L. Carpenter, MD, Howard A. Britton, MD, Josef T. Prchal, MD, Martha P. Mims, MD, PhD

Blood (2005) 106 (11): 3847.

https://doi.org/10.1182/blood.V106.11.3847.3847

Published: 2005

Journal Articles

DNA Sequence of Hemoglobin Chico.

Aaron M. Fond, Stephen Neville, MD, John Gotchall, MD, Enli Liu, MD, Ching-Nan Ou, PhD, Cheryl L. Rognerud, Martha P. Mims, MD, PhD

Blood (2005) 106 (11): 3784.

https://doi.org/10.1182/blood.V106.11.3784.3784

Published: 2005

Journal Articles

Elevated Hemoglobin F in an African American Girl with HbS/β Thalassemia: Unraveling the Mechanism.

Aaron M. Fond, Josef T. Prchal, MD, Ching-Nan Ou, PhD, Cheryl L. Rognerud, Donald Mahoney, MD, Martha P. Mims, MD, PhD

Blood (2005) 106 (11): 3832.

https://doi.org/10.1182/blood.V106.11.3832.3832

Published: 2005

Journal Articles

Myelofibrosis in a Patient with Sarcoidosis.

Elham Abbasi, MD, Enli Liu, MD, Martha P. Mims, MD, Phd, Mark M. Udden, MD

Blood (2005) 106 (11): 4965.

https://doi.org/10.1182/blood.V106.11.4965.4965

Published: 2005

Journal Articles

Duffy Antigen/Receptor for Chemokines (DARC): Is There a Role in Prostate Cancer?.

Samuel B. Anyona, BS, Shiyan Zheng, MD, Thomas Wheeler, MD, Michael Ittmann, MD, PhD., Teresa G. Hayes, MD, PhD, Martha P. Mims, MD, PhD

Blood (2005) 106 (11): 4394.

https://doi.org/10.1182/blood.V106.11.4394.4394

Published: 2005

Journal Articles

Granulocytic Sarcoma in Erythroleukemia (M6).

Elham Abbasi, MD, Martha P. Mims, MD, PhD, Mark M. Udden, MD.

Blood (2005) 106 (11): 4629.

https://doi.org/10.1182/blood.V106.11.4629.4629

Published: 2005

NARROW

SWOG 1312 Final Results: A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemia

Safety Analysis of Two Randomized Controlled Studies of Venetoclax in Patients with Chronic Lymphocytic Leukemia

Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk Stratification

Safety Analysis of Five Randomized Controlled Studies of Daratumumab in Patients with Multiple Myeloma

Superior Outcome in Elderly AML Patients Receiving Adjuvant Serotonin-Reuptake-Inhibitors during Induction

A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemia (SWOG 1312)

Traceable Red Cell Distribution Width Modifications Are Observed Prior to MDS Diagnosis and Primarily Associated with Cardiovascular Organ Dysfunction

Southwest Oncology Group Study S0530: A Phase 2 Trial of Clofarabine/ Cytarabine for Relapsed/ Refractory Acute Lymphocytic Leukemia.

8p11–12 Myeloprolferative Syndrome: A Case Report and Brief Review of the Literature

Polyclonal PRAME-Specific Cytotoxic T Lymphocytes Generated Using Protein-Spanning Pools of Overlapping Pentadecapeptides Target Chronic Myeloid Leukemia

Risk and Therapeutic Outcomes in a Multiethnic Group of Acute Lymphoblastic Leukemia Patients Treated at a Large Public Hospital

Presence of Alpha Thalassemia Trait Complicating the Diagnosis of Polycythemia Vera in a Pediatric Patient.

DNA Sequence of Hemoglobin Chico.

Elevated Hemoglobin F in an African American Girl with HbS/β Thalassemia: Unraveling the Mechanism.

Myelofibrosis in a Patient with Sarcoidosis.

Duffy Antigen/Receptor for Chemokines (DARC): Is There a Role in Prostate Cancer?.

Granulocytic Sarcoma in Erythroleukemia (M6).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only